TNFSF10 and cancer: The ability of doxorubicin to synergize TRAIL-induced apoptosis demonstrates a critical interplay between the extrinsic and the intrinsic apoptotic pathways [7]–[10] that can be exploited to more effectively kill cancer cells while reducing the undesirable side effects of high dose chemotherapy.